The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume. Read more about The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.
Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results? Read more about Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results?
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI. Read more about Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications. Read more about Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.
Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm. Read more about Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm.
MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. Read more about MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization. Read more about Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization.
MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis. Read more about MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
Screening for Breast Cancer in Women Age 75 Years and Older. Read more about Screening for Breast Cancer in Women Age 75 Years and Older.
Screening Mammography in Women 40-49 Years Old: Current Evidence. Read more about Screening Mammography in Women 40-49 Years Old: Current Evidence.